MétaCan
Menu
Back to cohort
Record W7135091462 · doi:10.1093/neuped/wuaf001.149

HGG-14. Immune checkpoint inhibitors in children with replication repair deficient high-grade gliomas: The South London Paediatric & TYA Neuro-Oncology Network experience.

2025· article· en· W7135091462 on OpenAlex
Marta Perez-Somarriba, Anna Campello, Philip Benjamin, Zita Reisz, Prof Safa Al-Sarraj, Leslie Bridges, Thomas Jacques, Vanessa Bianchi, Lucie Stengs, Bassel Zebian, Cristina Bleil, Kristian Aquilina, Samantha Hettige, Angela Mastronuzzi, Kavitha Srivatsa, Julia Cockle, Henry Mandeville, Lynley V. Marshall, Chris Jones, Álvaro Lassaletta, Anirban Das, Uri Tabori, Fernando Carceller

Why this work is in the frame

A frame that forgets how it found something cannot be audited. These are the routes that admitted this work.

affAt least one author lists a Canadian institution in the pinned OpenAlex snapshot.

Bibliographic record

VenueNeuro-Oncology Pediatrics · 2025
Typearticle
Languageen
FieldMedicine
TopicGlioma Diagnosis and Treatment
Canadian institutionsInstitute of Cancer ResearchHospital for Sick Children
Fundersnot available
KeywordsRituximabLymphomaBurkitt's lymphomaRetrospective cohort studyPhenotypePeripheral T-cell lymphomaProportional hazards modelGermline mutation

Abstract

fetched live from OpenAlex

Abstract Background Pediatric high-grade gliomas (pHGG) are the most common intracranial tumors in children with replication repair deficiency (RRD) syndromes. The hypermutant phenotype constitutes a vulnerability to immune checkpoint inhibitors (ICI). However, responses are variable, and resistance mechanisms are not fully understood. Methods Single-institution retrospective review from children and adolescents diagnosed with HGG and molecularly confirmed RRD treated at the South London Paediatric and TYA Neuro-Oncology Network between January 2000 and December 2023. Clinical, histopathological, molecular, genetic, therapeutic and survival data were collected. Descriptive statistics, Kaplan-Meier and univariable Cox proportional hazard models were used. Results Six cases were identified (3 females). Median age was 9.6 years (range 2.74-11.02). Five supratentorial and one spinal HGG. Germline genetic testing confirmed heterozygous MMR gene variants (Lynch Syndrome) in 4 cases (67%) and homozygous (CMMRD syndrome) in 2 (33%). Tumour Mutational Burden was available for 3 patients, of whom two presented additional mutations in POLE/POLD2 and ultrahypermutant phenotype. Two children were treated with ICI upfront, two at relapse and two upfront and at relapse. One presented a synchronous Burkitt Lymphoma and received sequential rituximab and ICI after initial surgery; another developed a metachronous lymphoblastic lymphoma whilst on ICI for pHGG. Two cases developed hypothyroidism grade 2. Grade 3 toxicities included (n = 1 each): elevated AST/ALT and new onset of insulin-dependent diabetes. No grade 4 toxicities. Five cases (83%) died of disease: median OS 11.4 months (range 10.0-35.8). One patient remains in complete remission 26.5 months after initial diagnosis. The two patients with ultrahypermutant phenotype presented the longest survival. Conclusions Although ICI have a molecularly-driven rationale to treat RRD-HGG, the best agent, optimal drug combinations, and best predictive biomarkers yet remain to be elucidated. Collaboration with expert initiatives such as the International Replication Repair Deficiency Consortium (IRRDC) is essential to continue developing better tailored treatments for these children.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.001
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesMeta-epidemiology (narrow)
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.054
Threshold uncertainty score1.000

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0010.001
Meta-epidemiology (narrow)0.0010.000
Meta-epidemiology (broad)0.0010.000
Bibliometrics0.0010.004
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0010.001
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.012
GPT teacher head0.271
Teacher spread0.258 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it